Kernal Biologics logo

Kernal Biologics

Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.

3

Funding Rounds

$50.6m

Money raised

Overview

Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.

Funding

Funding series

Funding Series Analysis

The company Kernal Biologics has raised a total of $50.6m in funding over 3 rounds.

Key Insights:

  • Kernal Biologics Series A round, July 2022: $25m
  • Kernal Biologics Funding Round, February 2022: $25.47m
  • Kernal Biologics Seed round, August 2020: $125k
Kernal Biologics logo
Kernal Biologics Series A round, July 2022 $25m
Kernal Biologics logo
Kernal Biologics Funding Round, February 2022 $25.47m
Kernal Biologics logo
Kernal Biologics Seed round, August 2020 $125k